S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 561 to 580 of 4,025

Issue Date	Title / Author(s) / Citation	File
2021-09	Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK plus non-small cell lung cancer (NSCLC): Final results of the Phase 1/2 and Phase 2 (ALTA) trials Huber, R.; Gettinger, S.; Kim, D. -W; Bazhenova, L.; Hansen, K.; Tiseo, M.; Langer, C.; Paz-Ares Rodriguez, L.; West, H.; Reckamp, K.; Weiss, G.; Smit, E.; Hochmair, M.; Kim, S. -W; Ahn, M. -J; Kim, E.; Groen, H.; Pye, J.; Vranceanu, F.; Camidge, D. R. Oncology Research and Treatment, Vol.44, pp.4-5
2020-03	Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial Huber, Rudolf M.; Hansen, Karin H.; Paz-Ares Rodriguez, Luis; West, Howard L.; Reckamp, Karen L.; Leighl, Natasha B.; Tiseo, Marcello; Smit, Egbert F.; Kim, Dong-Wan; Gettinger, Scott N.; Hochmair, Maximilian J.; Kim, Sang-We; Langer, Corey J.; Ahn, Myung-Ju; Kim, Edward S.; Kerstein, David; Groen, Harry J. M.; Camidge, D. Ross Journal of Thoracic Oncology, Vol.15 No.3, pp.404-415	DOI
2017-08	Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial Kim, Dong-Wan; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen L.; Hansen, Karin Holmskov; Kim, Sang-We; Huber, Rudolf M.; West, Howard L.; Groen, Harry J. M.; Hochmair, Maximilian J.; Leighl, Natasha B.; Gettinger, Scott N.; Langer, Corey J.; Rodriguez, Luis G. Paz-Ares; Smit, Egbert F.; Kim, Edward S.; Reichmann, William; Haluska, Frank G.; Kerstein, David; Camidge, D. Ross Journal of Clinical Oncology, Vol.35 No.22, pp.2490-2498	DOI
2023-12	Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial Yang, James Chih-Hsin; Liu, Geoffrey; Lu, Shun; He, Jianxing; Burotto, Mauricio; Ahn, Myung-Ju; Kim, Dong-Wan; Liu, XiaoQing; Zhao, Yanqiu; Vincent, Sylvie; Yin, Jiani; Ma, Xin; Lin, Huamao M.; Popat, Sanjay Journal of Thoracic Oncology, Vol.18 No.12, pp.1743-1755	DOI
2020-11	Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria Rosario; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Gupta, Neeraj; Hanley, Michael J.; Ni, Quanhong; Zhang, Pingkuan; Popat, Sanjay Journal of Clinical Oncology, Vol.38 No.31, pp.3592-3603	DOI
2021-12	Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Campelo, D. h Maria Rosario Garcia; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander I.; Gettinger, Scott N.; Tiseo, Marcello; Lin, Huamao M.; Liu, Yuyin; Vranceanu, Florin; Niu, Huifeng; Zhang, Pingkuan; Popat, Sanjay Journal of Thoracic Oncology, Vol.16 No.12, pp.2091-2108	DOI
2018-11	Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin -H.; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Ffrank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay New England Journal of Medicine, Vol.379 No.21, pp.2027-2039	DOI
2020-09	Brimonidine-montmorillonite hybrid formulation for topical drug delivery to the eye Park, Chun Gwon; Choi, Goeun; Kim, Myung Hun; Kim, Se-Na; Lee, Hanna; Lee, Na Kyeong; Choy, Young Bin; Choy, Jin-Ho Journal of Materials Chemistry B, Vol.8 No.35, pp.7914-7920	DOI
2021-01	Bronchovascular bundle thickening on CT as a predictor of survival and brain metastasis in patients with stage IA peripheral small cell lung cancer Sung, P.; Yoon, S. H.; Kim, J.; Hong, J. H.; Park, S.; Goo, J. M. Clinical Radiology, Vol.76 No.1, pp.76.e37-76.e46	DOI
2014-03	Buddy Taping: Is It a Safe Method for Treatment of Finger and Toe Injuries? Won, Sung Hun; Lee, Sanglim; Chung, Chin Youb; Lee, Kyoung Min; Sung, Ki Hyuk; Kim, Tae Kyun; Choi, Young; Lee, Sang Hyeong; Kwon, Dae Gyu; Ha, Jae Hong; Lee, Seung Yeol; Park, Moon Seok Clinics in Orthopedic Surgery, Vol.6 No.1, pp.26-31	DOI
2022-09	Building and implementing a contactless clinical trial protocol for patients with COVID-19: A Korean perspective Bae, Ye Seul; Sung, Sumi; Lee, Jungeun; Lee, Hyeonji; Chie, Eui Kyu Frontiers in Medicine, Vol.9, p. 975243	DOI
2018-11	Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2 Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortes, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le Mouhaer, Sylvie; Sankaran, Banu; Bourdeau, Laurence; El-Hashimy, Mona; Sellami, Dalila; Baselga, Jose European Journal of Cancer, Vol.103, pp.147-154	DOI
2017-07	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial Baselga, Jose; Im, Seock Ah; Iwata, Hiroji; Cortes, Javier; De laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L.; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Takahashi, Masato; Vuylsteke, Peter; Hachemi, Soulef; Dharan, Bharani; Di Tomaso, Emmanuelle; Urban, Patrick; Massacesi, Cristian; Campone, Mario The Lancet Oncology, Vol.18 No.7, pp.904-916	DOI
2022	Burden of disease of X hiked hypophosphatemia in Japanese and Korean patients: a cross-sectional survey Ito, Nobuaki; Kang, Hee Gyung; Nishida, Yayoi; Evins, Ayla; Skrinar, Alison; Cheong, Hae Il Endocrine Journal, Vol.69 No.4, pp.373-383	DOI
2022-09	Burning chest pain as a prodromal sign in autopsy- proven Parkinson's disease dementia Yoo, Dallah; Park, Sung-Hye; Kim, Man Jin; Ahn, Tae-Beom Neurology Asia, Vol.27 No.3, pp.795-798	DOI
2019-04	C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics Kim, Kipyo; Son, Hyung-Eun; Ryu, Ji-Young; Lee, Hajeong; Han, Seung Hyeok; Ryu, Dong-Ryeol; Paik, Jin Ho; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Oh, Se Won PLoS ONE, Vol.14 No.4, p. e0215217	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2022-10	Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma Lee, Hye Won; Seo, Hee Seung; Yeom, Seon-Yong; Kim, Se-Na; Kim, Cho Rim; Park, Dae-Hwan; Park, Wooram; Choy, Young Bin; Park, Chun Gwon; Seo, Seong Il International Journal of Molecular Sciences, Vol.23 No.20, p. 12634	DOI
2010-02	CADPE Suppresses Cyclin D1 Expression in Hepatocellular Carcinoma by Blocking IL-6-induced STAT3 Activation Won, Cheolhee; Lee, Chang Seok; Lee, Jin-Ku; Kim, Tack-Joong; Lee, Kwang-Ho; Yang, Young Mok; Kim, Yong-Nyun; Ye, Sang-Kyu; Chung, Myung-Hee Anticancer Research, Vol.30 No.2, pp.481-488
2020-12	Caffeoyl-Pro-His amide relieve DNCB-Induced Atopic Dermatitis-Like phenotypes in BALB/c mice Jang, Sunhyae; Ohn, Jungyoon; Kim, Ji Won; Kang, So Min; Jeon, Dasom; Heo, Chan Yeong; Lee, Yoon-Sik; Kwon, Ohsang; Kim, Kyu Han Scientific Reports, Vol.10 No.1, p. 8417	DOI

1 25 26 27 28 29 30 31 202